Pharmacy News

Could GLP-1s benefit T1D patients, too?

The popular GLP-1 receptor agonists, originally approved for T2D, may also be beneficial for patients with T1D—at least, that’s what findings from a small study published in NEJM imply.

CDC: Overdose deaths from counterfeit drugs on the rise

A new report from CDC finds that in recent years, the number of people who overdosed and died from counterfeit prescription drugs has more than doubled. From mid-2019 to the end of 2021, overdose deaths involving counterfeit drugs increased from 2% to 4.7%.

Postnatal SSRI treatment could benefit both mother and child

Findings from a recent study published in JAMA Network Open suggest that postnatal SSRI treatment may bring benefits in the long term to not only mothers, but also their offspring.

USPSTF’s new PrEP recommendation aims for more choices, greater impact

According to a new recommendation statement published in JAMA, the U.S. Preventive Services Task Force (USPSTF) recommends PrEP for those at high risk of contracting HIV to comprise newer antiretroviral drugs, including a long-acting option.

Is PPI use connected to dementia risk?

The prolonged use of PPI drugs, which are designed to control acid reflux and other gastrointestinal disorders, may raise the risk of dementia, according to a new study in Neurology.